Roxadustat advances as a promising oral treatment for anemia in lower-risk myelodysplastic syndromes, targeting high ...

Investing.com -- FibroGen Inc (NASDAQ: FGEN) stock jumped 9.9% following positive feedback from the U.S. Food and Drug Administration supporting the advancement of roxadustat for treating anemia in ...

Total knee arthroplasty is a commonly performed procedure with postoperative complications including blood loss, pain, and ...

Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course ...

If you’ve ever been elbows-deep in a pediatric spinal deformity correction thinking, “We are rapidly running out of ...

Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for HyHub TM and HyHub TM Duo, devices for patients 17 years of age and older ...

FibroGen has reached agreement with the FDA on important design elements for a pivotal Phase 3 clinical trial for roxadustat for the treatment of anemia in patients with lower-risk myelodysplastic ...

Dells-Delton EMS, Reedsburg Ambulance and Baraboo Area Fire and EMS have each administered blood in the field since launching ...

Spain has lifted a long-term blood donation ban on British nationals and former UK residents who lived in the country during ...

I was born in 1954, and my mother took diethylstilbestrol (DES) to prevent miscarriages. I had a hysterectomy last year, and ...

Speaking at a review meeting held at the Directorate of Health Services in Mumbai, Abitkar said that inclusion in the ...

Challenges persist despite promising advance In January 2025, the National Institute for Health and Care Excellence (NICE) approved the use of the gene editing therapy exagamglogene autotemcel ...